Spero Therapeutics, Inc. (SPRO) — Stock Score Summary

Spero Therapeutics, Inc. (SPRO) has a MoatMap StockRank of 94/100 based on Quality (72/100), Value (56/100), and Momentum (52/100) factor scores. The current signal is STRONG BUY.

Spero Therapeutics, Inc. is a biopharmaceutical company focused on developing novel antibiotics for multi-drug resistant bacterial infections. The company's lead product candidates aim to address serious unmet medical needs in conditions like complicated urinary tract infections and hospital-acquired pneumonia. Its dedication to combating antibiotic resistance positions Spero in a critical, high-barrier-to-entry niche within the pharmaceutical industry, addressing a global public health crisis.

Key Financial Metrics

Price$2.58
Market Cap$160M
P/E (TTM)9.59
P/E (Forward)-2.33
Price/Book2.48
Return on Equity35.1%
Return on Invested Capital11.9%
Debt/Equity4.67
Gross Margin37.1%
Operating Margin-2921.7%
Revenue Growth-95.6%
Free Cash Flow$14M

Spero Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Spero Therapeutics, Inc.’s (SPRO) StockRank?
MoatMap’s StockRank for Spero Therapeutics, Inc. (SPRO) is 94/100, with a Strong Buy signal. It is a composite of Quality (72), Value (56), and Momentum (52) factor ranks across MoatMap’s 15,000+ stock universe.
Does Spero Therapeutics, Inc. have an economic moat?
Spero Therapeutics, Inc. (SPRO) has a Quality factor score of 72/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Spero Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Spero Therapeutics, Inc. (SPRO) is Strong Buy, based on a StockRank of 94/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Spero Therapeutics, Inc. in?
Spero Therapeutics, Inc. (SPRO) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksSPRO deep dive reportAI ChampionsHow we score stocksSense-check another stock